Concepedia

Aklile Berhanu

AB

Statistics

Publications

12

Citations

859

H-Index

12

Active since

2001

Affiliations

Siga Technologies (United States)(Current)

Southern Research Institute

University of Pittsburgh

Aklile Berhanu is an author at Siga Technologies (United States) specializing in infectious diseases, immunology, and vaccinology.

Publications per year

2001–2019

12

Publications

12

A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Chelsea M. Byrd, Dongcheng Dai, Douglas W. Grosenbach et al. · Antimicrobial Agents and Chemotherapy · 2012 · 164 citations · Full text

, , +17

Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

Chelsea M. Byrd, Douglas W. Grosenbach, Aklile Berhanu et al. · Antimicrobial Agents and Chemotherapy · 2013 · 112 citations · Full text

, , +17

Treatment with the Smallpox Antiviral Tecovirimat (ST-246) Alone or in Combination with ACAM2000 Vaccination Is Effective as a Postsymptomatic Therapy for Monkeypox Virus Infection

Aklile Berhanu, Jonathan T. Prigge, Peter Silvera et al. · Antimicrobial Agents and Chemotherapy · 2015 · 108 citations · Full text

, , +16

Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge

Andrew T. Russo, Aklile Berhanu, Catherine B. Bigger et al. · Vaccine · 2019 · 104 citations · Full text

, , +12

Vaccination of BALB/c Mice with<i>Escherichia coli</i>-Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge

Aklile Berhanu, Rebecca L. Wilson, Dana L. Kirkwood-Watts et al. · Journal of Virology · 2008 · 102 citations · Full text

, , +17

1–5 of 12